The Journal of Rheumatology 2011

3 papers
In 2011, *The Journal of Rheumatology* featured research focused on cardiovascular risk assessment, therapeutic management, and the cellular mechanisms of joint destruction. One area of study involved evaluating biomarkers such as NT-proBNP and high-sensitivity C-reactive protein to predict cardiovascular outcomes in patients using long-term nonsteroidal anti-inflammatory drugs (NSAIDs). This work utilized multivariate modeling and quantile stratification to refine clinical risk stratification and identify non-linear risk gradients. Additionally, the journal addressed clinical challenges in immunomodulation, specifically the management of patients who develop anti-TNF-induced lupus. Research explored the feasibility of switching to alternative anti-TNF agents as a therapeutic strategy. Pathological studies also highlighted the role of specific B cell markers, finding that synovial infiltration with CD79a-positive B cells correlates with joint destruction in rheumatoid arthritis. Contributions from authors such as David A. Morrow and Christopher P. Cannon emphasized the integration of myocardial strain analysis and prognostic factors into rheumatological care.

Top Research Directions

The 8 research directions with The Journal of Rheumatology 2011 papers, ranked by paper count, next to 2009. Share is the fraction of the edition’s papers in the direction.

#Direction20112009Share 2011Share 20092009 rank
1Cellular and Systemic Drivers of Joint Destruction in Arthritis1033.3%0.0%—
2Myocardial Strain Imaging Beyond Ejection Fraction1033.3%0.0%—
3Non-Parametric Rank Correlation Analysis1033.3%0.0%—
4Proportional Hazards Modeling for Survival Analysis1033.3%0.0%—
5Quantifying Diagnostic Accuracy Using ROC Curve Analysis1033.3%0.0%—
6Quantile Based Stratification for Dose Response Analysis1033.3%0.0%—
7Tracking Dynamic Biomarker Trajectories Over Time1033.3%0.0%—
8Vascular and Structural Fragility Induced by Chronic Therapeutics1033.3%0.0%—

Download all directions as CSV

Institutions

Institutions credited by The Journal of Rheumatology 2011 papers: a paper credits every institution named in its affiliations, once. 10 institutions share 3 credited papers.

#InstitutionPapersShare20092009 rank
101px77p81 133.3%0—
205vp7ha71 133.3%0—
3Brigham and Women's Hospital 133.3%0—
4Friedrich-Alexander-Universität Erlangen-Nürnberg 133.3%0—
5Harvard Medical School 133.3%0—
6Helmholtz Centre for Infection Research 133.3%0—
7Sun Yat-sen University 133.3%0—
8University of Alberta 133.3%0—
9University of Calgary 133.3%0—
10University of Southern California 133.3%0—

Download all institutions as CSV

About this data

Papers. The Journal of Rheumatology 2011 lists 3 papers on Lacuna, duplicate versions counted once; rejected and withdrawn submissions are left out.

Directions. Directions are Lacuna’s clustering of the concept elements extracted from each paper, so a paper can belong to several and direction counts add up to more than the paper count. A direction’s share is its papers divided by the edition’s papers. Comparisons with 2009 use shares, since the edition went from 2 to 3 papers.

Institutions. A paper credits each institution named in its affiliations, resolved to a ROR record, once. 3 of 3 papers (100.0%) credit at least one institution and are the base for institution shares; the rest have no resolved affiliation yet.

Data. Counts come from Lacuna’s data build of 2026-11-17 and change as papers are added. Tables as CSV: directions · institutions. Cite as: Lacuna, “The Journal of Rheumatology 2011”, https://lacuna.tiptreesystems.com/venue/the-journal-of-rheumatology/2011.

Top Authors

AuthorPapers
Carrie Ye1

Impactful Papers

Papers from The Journal of Rheumatology 2011 that shaped research clusters.

Foundational

Influential

Papers

Title
Evaluation of NT-proBNP and High Sensitivity C-Reactive Protein for Predicting Cardiovascular Risk in Patients with Arthritis Taking Longterm Nonsteroidal Antiinflammatory Drugs
Successful Switch of Patients with Rheumatoid Arthritis Developing Anti-tumor Necrosis Factor (anti-TNF)-induced Lupus to Another Anti-TNF Agent
Synovial Infiltration with CD79a-positive B Cells, But Not Other B Cell Lineage Markers, Correlates with Joint Destruction in Rheumatoid Arthritis